Impact of Massage Therapy on the Quality of Life of Hospice Patients

Not Applicable

Completed

• Conditions: Anxiety; Quality of Life; Depression; Pain
• Interventions: Other: Massage Therapy

• Registration Number: NCT02880202
• Lead Sponsor: Mayo Clinic

Brief Summary

This is a pilot study to evaluate the impact of massage therapy in hospice patients.

Detailed Description

As an integrative therapy, there is growing evidence that massage therapy can be an effective therapeutic tool for relief of pain and non-pain symptoms in hospice and palliative care patients. Massage therapy can provide comfort, relaxation, and improve quality of life for patients. The primary aim of the study is to gather data on the effects of complementary massage therapy on patient's symptoms and quality of life. The study goal is to improve patient symptoms of pain, anxiety, depression, and quality of life through the use of massage therapy provided to hospice patients. Questionnaires would be utilized before and after each massage intervention and would quantify symptom and quality of life levels.

Study Timeline

• Study Start: 2016-08
• Study First Submitted: 2016-08-18
• Study First Submitted QC: 2016-08-22
• Study First Posted: 2016-08-26
• Primary Completion: 2018-11
• Status Verified: 2018-12
• Study Completion: 2018-12
• Last Update Submitted: 2018-12-21
• Last Update Posted: 2018-12-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

1. Age 18 years or older
2. Clinically determined by hospice staff to be appropriate for massage therapy (ESAS-r scores of 5 or greater on pain, depression, anxiety, or best well-being)
3. Place of residence within 30 minutes of downtown Rochester
4. Patient or caregiver must be able to participate in brief interviews and complete questionnaires (verbally or physically)

Exclusion Criteria

1. Patients ineligible for massage therapy due to complexity of medical care including complex wound and multiple drains

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Massage Therapy	Massage Therapy	Massage therapy for hospice patients.

Primary Outcome Measures

Name	Time	Method
Change in Edmonton Symptom Assessment System - Revised	Baseline to 3 weeks	The primary endpoints are patient pain, depression, anxiety and wellbeing as measured by ESAS-r. Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores. The pro-rated AUC for ESAS-r measured pain, depression, anxiety, and wellbeing will all be utilized individually to assess the primary endpoint. The pro-rated AUC will be compared to the assessment score prior to any massage therapy. If there is any improvement, the massage therapy will be considered a success since any improvement will be seen as beneficial.

Secondary Outcome Measures

Name	Time	Method
Change in Edmonton Symptom Assessment System - Revised (Other symptoms)	Baseline to 3 weeks	Secondary endpoints include all other symptoms (tiredness, drowsiness, nausea, lack of appetite, shortness of breath) as measured by the ESAS-r. Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome. Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores.
Change in Linear Analogue Self Assessment (LASA)	Baseline to 3 weeks	Secondary endpoints include symptoms as measured by the LASA (overall quality of life \[QOL\], mental well-being, physical well-being, emotional well-being, social activity, spiritual well-being, pain frequency, pain severity, fatigue, and social support). LASA items are stand alone, thus no scoring is necessary, but individual LASA items may be transposed so lower scores mean worse symptoms and higher scores mean less symptoms. This will allow consistency and thus easier data interpretation. Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores. Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
Change in Patient Health Questionnaire for Depression and Anxiety (PHQ-4)	Baseline to 3 weeks	Secondary endpoints include depression and anxiety symptoms as measured by the PHQ-4. Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.
Change in Pearlin role overload measure (ROM)	Baseline to 3 weeks	Secondary endpoints include caregiver stress as measured by the ROM. Pro-rated area under the curve (AUC) statistics will be calculated for all individual items and total scores. Similar analysis will be conducted for all other endpoints as was conducted for the primary outcome.

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States